Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Stanford University
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Stanford University Identifier:
First received: June 26, 2012
Last updated: May 18, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)